Effects of metoprolol on myocardial β-adrenoceptors and Giα-proteins in patients with congestive heart failure
暂无分享,去创建一个
M. Steinfath | W. Schmitz | P. Hanrath | M. Sigmund | T. Eschenhagen | H. Jakob | H. Scholz | C. Schumacher | H. Becker
[1] M. Steinfath,et al. Chronic treatment with carbachol sensitizes the myocardium to cAMP-induced arrhythmia. , 1996, Circulation.
[2] S. Coughlin,et al. Idiopathic dilated cardiomyopathy. , 1994, The New England journal of medicine.
[3] Å. Hjalmarson,et al. Beta-blocker treatment for chronic heart failure. The frog prince. , 1994, Circulation.
[4] T. Eschenhagen. G proteins and the heart , 1993, Cell biology international.
[5] O. Brodde. Beta-adrenoceptors in cardiac disease. , 1993, Pharmacology & therapeutics.
[6] S. Harding,et al. The effect of pertussis toxin on β‐adrenoceptor responses in isolated cardiac myocytes from noradrenaline‐treated guinea‐pigs and patients with cardiac failure , 1992, British journal of pharmacology.
[7] L. Mestroni,et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. , 1992, The Journal of clinical investigation.
[8] O. Brodde. Beta 1- and beta 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. , 1991, Pharmacological reviews.
[9] M. Steinfath,et al. Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors in different human heart diseases. , 1991, Naunyn-Schmiedeberg's archives of pharmacology.
[10] M. Brown,et al. Selective j31-Adrenoceptor Blockade Enhances Positive Inotropic Responses toEndogenous Catecholamines Mediated Through j2-Adrenoceptors inHumanAtrial Myocardium , 1990 .
[11] P. Poole‐Wilson. Idiopathic dilated cardiomyopathy. , 1990, BMJ.
[12] D. Renlund,et al. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. , 1990, The American journal of medicine.
[13] K Caidahl,et al. Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. , 1989, Circulation.
[14] H. Valantine,et al. Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. , 1989, Circulation.
[15] W. Schmitz,et al. INCREASE IN MYOCARDIAL Gi-PROTEINS IN HEART FAILURE , 1988, The Lancet.
[16] M. Böhm,et al. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. , 1988, European heart journal.
[17] W. Baumgartner,et al. Increase of the 40,000-mol wt pertussis toxin substrate (G protein) in the failing human heart. , 1988, The Journal of clinical investigation.
[18] J. Cohn,et al. The autonomic nervous system in congestive heart failure. , 1986, Annual review of medicine.
[19] N. Kantrowitz,et al. Beta-adrenergic function in heart muscle disease and heart failure. , 1985, Journal of molecular and cellular cardiology.
[20] J. Cohn,et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.
[21] D C Harrison,et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. , 1982, The New England journal of medicine.
[22] K. Swedberg,et al. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. , 1980, British heart journal.
[23] E. Varnauskas,et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.
[24] G. Scatchard,et al. THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .